Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.
Also called NCT03096613
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 124 participants
- Sponsor
- Registry
-
NCT03096613
-
- Other papers using this trial's data
- Effects of levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: An open-label randomized trial
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03096613. Randomized; no masking; primary purpose treatment. Start 2017-04-18 (actual); primary completion 2019-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
- Condition
- Heart Failure
- Condition
- Subclinical Hypothyroidism
- Intervention (Drug)
- Levothyroxine
- Lead sponsor
- Chinese Academy of Medical Sciences, Fuwai Hospital
- Collaborator
- The Luhe Teaching Hospital of the Capital Medical University
- Collaborator
- Tianjin Medical University Second Hospital
- Collaborator
- The First Hospital of Hebei Medical University
- Collaborator
- Henan Provincial People's Hospital
Record details
- Record id
cardio:ct-nct03096613- Content hash
8dc6862771701b22908dc659fcbf58b415feba4d4c5826beba4cecfc6058d8d6